Pharma giant GlaxoSmithKline to pump £275 million into Hertfordshire site

GlaxoSmithKline has given the UK life sciences industry a major boost in the post-Brexit landscape with an announcement that £275 million will be invested in manufacturing sites in Co. Durham, Hertfordshire and Scotland.

GSK is expecting to create new employment opportunities and says the decision is down of the skilled workforce here and the UK's leading position in life sciences. It's positive news following the Brexit vote to leave the European Union, which has brought varied economic uncertainty and worrying delays in investment decisions.

GSK employs 16,000 people in Britain. The new investment at Ware is close to two of the company's other sites in Stevenage and Harlow. On the northern outskirts of London.

All along the M11 corridor through Hertfordshire and Essex into Cambridgeshire, there is a concentration of science-based companies. In the past, the former Chancellor George Osborne highlighted the area for growing investment in the sector.